Lundbeck's CEO: Departing CFO is not defecting to competitor

Deborah Dunsire, CEO at Lundbeck, has yet to make plans for the nearest future after Chief Financial Officer Anders Götzsche has announced his departure from firm. He will remain at his post, however, until a successor has been appointed, and the company might look internally to find candidates, the CEO says.

Deborah Dunsire, CEO of Lundbeck | Photo: Gregers Tycho/ERH

After 14 years at Lundbeck, Chief Financial Officer Anders Götzsche will depart the Danish pharmaceutical firm no later than May 2022. He is set to join another, as of yet undisclosed, unlisted Danish company.

Deborah Dunsire, CEO at Lundbeck, expects to be able to announce where Götzsche is headed soon. However, it is safe to say that it isn't to one of Lundbeck's competitors, she tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs